ExerciseNCT07341165
Regulation of Satellite Cells and Myogenesis in Response to Eccentric Resistance Exercise in Hypoxia
A study testing Resistance exercise on an isokinetic dynamometer, Vastus lateralis biopsy and Blood samples in people with Exercise and Hypoxia, run by Université Catholique de Louvain at 1 site in Belgium.
Trial summary
Satellite cells (SC) are muscle stem cells that once activated, proliferate, and differentiate into myocytes that finally fuse with an existing myofiber to regenerate or increase its mass. This process is called 'myogenesis'. Satellite cell activation can be modulated by exercise and by hypoxia. Read more about this study
- Who is it for?
- Ages 20 to 49 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Exercise, Hypoxia, Satellite Cells
- What is being tested?
- Resistance exercise on an isokinetic dynamometer, Vastus lateralis biopsy and Blood samples
- Type of treatment
- Medical device, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 38 participants
- Where
- 1 siteBelgium
- Study dates
- 4 Apr 2023to 5 Sep 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 49 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Healthy man
- Aged between 20 and 49 years
- Physically active
- Not involved in resistance training,
- No exposed to high altitude (>1500m) 1 month before experiment
Who cannot join
- Intake of AINS,
- Illness with altered inflammatory status,
- Condition that prohibits resistance exercise (muscle injury) or the sampling of tissue biopsies (aspirin, anticoagulants, allergy to lidocaine)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Regulation of Satellite Cells and Myogenesis in Response to Eccentric Resistance Exercise in Hypoxic Conditions in Healthy Young Men
Satellite cells (SC) are muscle stem cells that once activated, proliferate, and differentiate into myocytes that finally fuse with an existing myofiber to regenerate or increase its mass. This process is called 'myogenesis'. Satellite cell activation can be modulated by exercise and by hypoxia. Hypoxia is a state of lower availability of oxygen that can be reached either by going at high altitude (hypobaric hypoxia) or by lowering the percentage of oxygen in hypoxic rooms at sea level. In opposition to the previously described systemic hypoxia, local hypoxia can be reached placing a cuff around a limb, which will induce a partial vascular occlusion. The latter is termed as blood flow restriction (BFR). In addition, in response to physical exercise, a local intramuscular hypoxia can be found back in the skeletal muscle. Myogenesis has been shown to be modulated by hypoxia in different ways, depending on the level of hypoxia: in conditions of mild hypoxia, satellite cell proliferation appears to be favorized, whereas SC differentiation is decreased in those conditions. In conditions of severe hypoxia, SC quiescence is promoted. SC activation increases in response to resistance training, with and without BFR. Some recent data also suggest that resistance exercise in hypoxic rooms may modulate SC activation, but this area is less well understood. Eccentric exercise may enhance SC activation in comparison to concentric contraction. Up to now, no study has analyzed SC activation and myogenesis in response to an eccentric exercise in hypoxia. Whereas macroscopic differences such as higher muscle force gains or hypertrophy, have been observed between normoxic and hypoxic resistance training, but could not be explained by the classical protein balance and growth factors, there is a need for a better understanding of the muscle response in hypoxia and several studies suggest a role of satellite cells and myogenesis in that difference. The purpose of this study is to elucidate whether or not satellite cells are regulated in a different way in response to an eccentric exercise in hypoxia comparing to normoxia. In addition, differences in SC activation between environmental normobaric hypoxia and BFR, two methods used to reach hypoxia at sea level, are not well understood yet. Finally, most of the studies evaluating myogenic response following a resistance exercise have only taken samples at two time-points, before and 24h after exercise in most of the cases. As the different steps of the myogenic process evolves over the days and may be enhanced or inhibited by hypoxic conditions, multiple time-points would be interesting to observe the evolution of the myogenic process. In that purpose, blood and skeletal muscle samples will be taken at different time-points to evaluate the progress of myogenesis following an acute eccentric exercise. Myogenic regulatory factors will be analyzed by RT-qPCR (mRNA), Western-Blot (protein) and immunofluorescence (localization). In addition, factors able to regulate myogenesis such as muscle damage, inflammation, growth factors, early-regulated genes, MAPK… will also be analyzed in order to understand if they play a role in response to hypoxic conditions.
- Conditions
- Exercise, Hypoxia, Satellite Cells, Myogenesis
- Being tested
- Resistance exercise on an isokinetic dynamometer, Vastus lateralis biopsy, Blood samples, Normoxia, Hypoxia
- Medical subject headings
- Motor Activity, Hypoxia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Resistance exercise on an isokinetic dynamometerDevice
Leg flexion/extension: 5 series of 15 repetitions at 60°/sec for the knee extension and 30°/sec for the knee flexion
Vastus lateralis biopsyProcedure or surgery
Biopsy taken in the vastus lateralis
Blood samplesProcedure or surgery
Blood samples taken from the antecubital vein
NormoxiaDevice
Environmental condition for exercise: in a pressurized chamber with a inspired oxygen fraction of 0.21 (sea level)
HypoxiaDevice
Environmental hypoxia: in a chamber where oxygen is extracted and replaced by nitrogen to reach an inspired oxygen fraction of 0.135 (equivalent to 2500m altitude)
Blood flow restrictionDevice
Tourniquet placed around the proximal extremity of the lower limb and inflated at 60% of arterial occlusion pressure to induce local hypoxia
| Study group | Role | What they receive |
|---|---|---|
| Resistance exercise in normoxia | Active comparator | Group that performed the resistance exercise in normoxia (FiO2=0.21) Receives: Device: Resistance exercise on an isokinetic dynamometer; Procedure: Vastus lateralis biopsy; Procedure: Blood samples; Device: Normoxia |
| Resistance exercise in hypoxia | Experimental | Group that performed the resistance exercise in hypoxia (FiO2=0.14) Receives: Device: Resistance exercise on an isokinetic dynamometer; Procedure: Vastus lateralis biopsy; Procedure: Blood samples; Device: Hypoxia |
| Resistance exercise with blood flow restriction | Experimental | Group that performed the resistance exercise with blood flow restriction (60%AOP) Receives: Device: Resistance exercise on an isokinetic dynamometer; Procedure: Vastus lateralis biopsy; Procedure: Blood samples; Device: Blood flow restriction |
What is being measured
The primary outcome is the main question the study is designed to answer.
Analysis of markers of satellite cells and myogenesis
Measured: Throughout the entire study, approximately during 30 months
Secondary outcomes (1)
Comparison of the differences between exercise in environmental and local hypoxia
Measured: Throughout the entire study, approximately during 30 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jan 2026
- Study start4 Apr 2023
- Primary completion8 May 2023
- Study completion5 Sep 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ExerciseStudies of the same condition, open and under way.
- More trials run by Université Catholique de LouvainThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 38 participants (actual)
Sponsor and investigators
- Lead sponsor
- Université Catholique de Louvain
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07341165
- Sponsor's protocol ID
- SCHYPECC
- Status last verified
- Jan 2026
- First submitted
- 19 Dec 2025
- Last updated
- 14 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Regulation of Satellite Cells and Myogenesis in Response to Eccentric Resistance Exercise in Hypoxic Conditions in Healthy Young Men
- ClinicalTrials.gov ID
- NCT07341165
- Acronym / sponsor ID
- SCHYPECC
- Conditions
- Exercise, Hypoxia, Satellite Cells, Myogenesis
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 38 participants (actual)
- Lead sponsor
- Université Catholique de LouvainUniversity, hospital or other
- Study start
- 4 Apr 2023 (actual)
- Primary completion
- 8 May 2023 (actual)
- Study completion
- 5 Sep 2025 (actual)
- First posted
- 14 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Satellite cells (SC) are muscle stem cells that once activated, proliferate, and differentiate into myocytes that finally fuse with an existing myofiber to regenerate or increase its mass. This process is called 'myogenesis'. Satellite cell activation can be modulated by exercise and by hypoxia. Hypoxia is a state of lower availability of oxygen that can be reached either by going at high altitude (hypobaric hypoxia) or by lowering the percentage of oxygen in hypoxic rooms at sea level. In opposition to the previously described systemic hypoxia, local hypoxia can be reached placing a cuff around a limb, which will induce a partial vascular occlusion. The latter is termed as blood flow restriction (BFR). In addition, in response to physical exercise, a local intramuscular hypoxia can be found back in the skeletal muscle. Myogenesis has been shown to be modulated by hypoxia in different ways, depending on the level of hypoxia: in conditions of mild hypoxia, satellite cell proliferation appears to be favorized, whereas SC differentiation is decreased in those conditions. In conditions of severe hypoxia, SC quiescence is promoted. SC activation increases in response to resistance training, with and without BFR. Some recent data also suggest that resistance exercise in hypoxic rooms may modulate SC activation, but this area is less well understood. Eccentric exercise may enhance SC activation in comparison to concentric contraction. Up to now, no study has analyzed SC activation and myogenesis in response to an eccentric exercise in hypoxia. Whereas macroscopic differences such as higher muscle force gains or hypertrophy, have been observed between normoxic and hypoxic resistance training, but could not be explained by the classical protein balance and growth factors, there is a need for a better understanding of the muscle response in hypoxia and several studies suggest a role of satellite cells and myogenesis in that difference. The purpose of this study is to elucidate whether or not satellite cells are regulated in a different way in response to an eccentric exercise in hypoxia comparing to normoxia. In addition, differences in SC activation between environmental normobaric hypoxia and BFR, two methods used to reach hypoxia at sea level, are not well understood yet. Finally, most of the studies evaluating myogenic response following a resistance exercise have only taken samples at two time-points, before and 24h after exercise in most of the cases. As the different steps of the myogenic process evolves over the days and may be enhanced or inhibited by hypoxic conditions, multiple time-points would be interesting to observe the evolution of the myogenic process. In that purpose, blood and skeletal muscle samples will be taken at different time-points to evaluate the progress of myogenesis following an acute eccentric exercise. Myogenic regulatory factors will be analyzed by RT-qPCR (mRNA), Western-Blot (protein) and immunofluorescence (localization). In addition, factors able to regulate myogenesis such as muscle damage, inflammation, growth factors, early-regulated genes, MAPK… will also be analyzed in order to understand if they play a role in response to hypoxic conditions.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Resistance exercise in normoxia | Active comparator | Device: Resistance exercise on an isokinetic dynamometer, Procedure: Vastus lateralis biopsy, Procedure: Blood samples, Device: NormoxiaGroup that performed the resistance exercise in normoxia (FiO2=0.21) |
| Resistance exercise in hypoxia | Experimental | Device: Resistance exercise on an isokinetic dynamometer, Procedure: Vastus lateralis biopsy, Procedure: Blood samples, Device: HypoxiaGroup that performed the resistance exercise in hypoxia (FiO2=0.14) |
| Resistance exercise with blood flow restriction | Experimental | Device: Resistance exercise on an isokinetic dynamometer, Procedure: Vastus lateralis biopsy, Procedure: Blood samples, Device: Blood flow restrictionGroup that performed the resistance exercise with blood flow restriction (60%AOP) |
Who may qualify
- Ages
- 20 to 49 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Healthy man
- Aged between 20 and 49 years
- Physically active
- Not involved in resistance training,
- No exposed to high altitude (>1500m) 1 month before experiment
Key exclusion criteria (3 listed)
- Intake of AINS,
- Illness with altered inflammatory status,
- Condition that prohibits resistance exercise (muscle injury) or the sampling of tissue biopsies (aspirin, anticoagulants, allergy to lidocaine)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Resistance exercise on an isokinetic dynamometerLeg flexion/extension: 5 series of 15 repetitions at 60°/sec for the knee extension and 30°/sec for the knee flexion | Device | Resistance exercise in hypoxia, Resistance exercise in normoxia, Resistance exercise with blood flow restriction |
| Vastus lateralis biopsyBiopsy taken in the vastus lateralis | Procedure or surgery | Resistance exercise in hypoxia, Resistance exercise in normoxia, Resistance exercise with blood flow restriction |
| Blood samplesBlood samples taken from the antecubital vein | Procedure or surgery | Resistance exercise in hypoxia, Resistance exercise in normoxia, Resistance exercise with blood flow restriction |
| NormoxiaEnvironmental condition for exercise: in a pressurized chamber with a inspired oxygen fraction of 0.21 (sea level) | Device | Resistance exercise in normoxia |
| HypoxiaEnvironmental hypoxia: in a chamber where oxygen is extracted and replaced by nitrogen to reach an inspired oxygen fraction of 0.135 (equivalent to 2500m altitude) | Device | Resistance exercise in hypoxia |
| Blood flow restrictionTourniquet placed around the proximal extremity of the lower limb and inflated at 60% of arterial occlusion pressure to induce local hypoxia | Device | Resistance exercise with blood flow restriction |
Primary outcome
Analysis of markers of satellite cells and myogenesis
Time frame: Throughout the entire study, approximately during 30 months
1 secondary outcome
Comparison of the differences between exercise in environmental and local hypoxia
Time frame: Throughout the entire study, approximately during 30 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jan 2026.
- Individual participant dataSharing planned: No
Related trials for Exercise
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruiting
Feasibility of a Robot-Guided Active Play Intervention for Children With Cerebral Palsy
Cerebral Palsy
Enrolling by invitation
Online Exercise Program for Transplant Patients: A Pilot Study
Kidney Transplantation, Physical Function
RecruitingPhase 4
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Heart Failure With Reduced Ejection Fraction, Iron Deficiency
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Resistance exercise on an isokinetic dynamometer, Vastus lateralis biopsy and Blood samples in people with Exercise and Hypoxia, run by Université Catholique de Louvain at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Analysis of markers of satellite cells and myogenesis (time frame: Throughout the entire study, approximately during 30 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2026.